Guidance: Payment to Research Subjects

There is no set guideline regarding the total amount of payment investigators may give to study participants. The IRBMED reviewers look at each project individually in order to asses the risks and benefits involved. Payments to subjects are not necessarily required.

The norms regarding acceptable levels of payment include:

Note: In most cases, reimbursement is more acceptable pro-rated. Lump sums are given only upon completion of the entire research project are generally not acceptable by the IRBMED, and investigators will be asked to revise lump-sum payments to be less coercive.

This page is maintained by UMHS Public Relations & Marketing Communications. Contact UMMS
(c) copyright 2013 Regents of the University of Michigan